Shambhavi Naik

By

All Things Policy: Regulating India’s Wet Markets

While a wet market in Wuhan has become notorious for being the likely place of origin of the SARS-CoV-2 virus, some of India’s own wet markets are plagued by problems like unhygienic conditions and the sale of endangered species. How...

All Things Policy: Is India Prepared for Gene Edited Humans?

The technology to modify the human genome is here, potentially signaling a transformation of societies and economies. In the light of WHO’s draft framework on governing human gene editing, Anirudh and Shambhavi discuss the ethical dilemmas, scientific challenges, and opportunities...
covid vaccine

All Things Policy: A COVID-19 Vaccine Made in India?

The ICMR recently stoked controversy by asking hospitals to participate in clinical trials for developing a COVID-19 vaccine by August 15. Is this a realistic deadline? What does it tell us about the state of scientific research in India? How...

Takshashila Discussion Document – COVID-19 Testing Strategy for India

Download this discussion document in PDF Executive Summary The rapidly spreading COVID-19 can be contained only with rapid, accurate testing and isolation of infected individuals. Various types of tests are available, but in India only select tests have been approved...

All Things Policy: COVID and Coronil

Ayurvedic formulations touting to cure COVID-19 have raised questions both about their claims and the scientific rigour of their clinical trials. Prateek Waghre talks to Sunila Dixit and Shambhavi Naik about Patanjali’s Coronil “immunity booster” and lessons to learn from...

Re-purposing vaccines for COVID-19: Need for context

The Sars-CoV-2 virus has befuddled scientists on two counts. First it is a novel virus, whose genetic structure was deduced only 6 months ago. Since then, a hunt for a cure or vaccine has been on. The virus is also...

The Compound Eye – The Epidemics Act 1987, Patanjali and STI policy 2020

Laws that Govern our Public Health Response to COVID-19  The on-going response to the COVID-19 outbreak in India has used lockdowns, quarantine measures and utilisation of apps for contact tracing. These policies have raised questions related to trade-offs between individual...

All Things Policy: COVID-19: A Testing Strategy for India

As COVID-19 continues to spread in India, it’s becoming clear that governments at all levels, not just the Union, need to get involved in fighting it. Dr. Shambhavi Naik joins Anirudh Kanisetti to discuss how India can make the most...

All Things Policy: Treating COVID-19

While much attention is paid to developing a vaccine for SARS-CoV-2, what are the treatments being tested or developed? Shambhavi Naik and Sunila Dixit join Aditya Ramanathan to look at the potential treatments and some promising new research. Also check...

All Things Policy: SARS-CoV-2 and the Biological Weapons Convention

 Most scientists have rubbished the idea that the novel coronavirus is a biological weapon. Their position could be bolstered by having the Biological Weapons Convention (BWC) to investigate the virus. Why hasn’t this happened? Shambhavi Naik joins Aditya Ramanathan...
1 3 4 5 6 7 19